CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Epicrispr lands $90M to advance epigenetic editing drug for rare muscle disease

Related Companies

Read the original article

Published by BioPharma Dive on August 11, 2026 12:00 PM

Read Original